|
Market Closed -
NYSE
16:03:20 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 92.07 USD | +0.99% |
|
-1.50% | +18.98% |
| 09-01 | Wells Fargo Adjusts Price Target on Ventas to $104 From $96, Maintains Overweight Rating | MT |
| 08-31 | Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VENTAS, INC. | Healthcare REITs | +0.99% | -1.50% | +18.98% | +35.24% | +64.59% | 46.77B |  | |  |
- Stock Market
- Stocks
- VTR Stock
- Charts Ventas, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
